Correlation Between CRISPR Therapeutics and TAL Education

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and TAL Education at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and TAL Education into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and TAL Education Group, you can compare the effects of market volatilities on CRISPR Therapeutics and TAL Education and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of TAL Education. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and TAL Education.

Diversification Opportunities for CRISPR Therapeutics and TAL Education

CRISPRTALDiversified AwayCRISPRTALDiversified Away100%
-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between CRISPR and TAL is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and TAL Education Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TAL Education Group and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with TAL Education. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TAL Education Group has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and TAL Education go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and TAL Education

Assuming the 90 days trading horizon CRISPR Therapeutics is expected to generate 3.95 times less return on investment than TAL Education. But when comparing it to its historical volatility, CRISPR Therapeutics AG is 1.29 times less risky than TAL Education. It trades about 0.02 of its potential returns per unit of risk. TAL Education Group is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  310.00  in TAL Education Group on December 12, 2024 and sell it today you would earn a total of  445.00  from holding TAL Education Group or generate 143.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.98%
ValuesDaily Returns

CRISPR Therapeutics AG  vs.  TAL Education Group

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-10010203040
JavaScript chart by amCharts 3.21.15C2RS34 T1AL34
       Timeline  
CRISPR Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar28303234363840
TAL Education Group 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in TAL Education Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, TAL Education sustained solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar5.566.577.588.5

CRISPR Therapeutics and TAL Education Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-6.26-4.69-3.12-1.550.0251.53.04.56.0 0.0200.0220.0240.026
JavaScript chart by amCharts 3.21.15C2RS34 T1AL34
       Returns  

Pair Trading with CRISPR Therapeutics and TAL Education

The main advantage of trading using opposite CRISPR Therapeutics and TAL Education positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, TAL Education can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TAL Education will offset losses from the drop in TAL Education's long position.
The idea behind CRISPR Therapeutics AG and TAL Education Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios